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Abstract The novel lipid second messenger, ceramide, induced 
apoptosis in PC 12 cells as determined morphologically by 
nuclear appearance and internucleosomal DNA fragmentation. 
Apoptosis was induced by exogenous CVceramide in a dose- and 
time-dependent manner. Natural ceramide and C6-ceramide had 
a similar effect. This response was specific since the structural 
analog C2-dihydroceramide and other related lipids failed to 
initiate apoptosis. The apoptotic effect of ceramide also depends 
critically on cell plating density. Furthermore, the peptide 
inhibitor of interleukin-lß converting enzyme (ICE)-like pro-
teases, Z-VAD.FMK, completely prevented the nuclear changes 
induced by ceramide, implicating the involvement of ICE-like 
protease activation in ceramide-induced apoptosis in PC12 cells. 
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1. Introduction 
Apoptosis is an evolutionary conserved and distinct form of 
programmed cell death characterised by an array of morpho-
logical criteria which include chromatin condensation, DNA 
fragmentation, cell shrinkage, and membrane blebbing [1,2]. 
Apoptosis is a critical feature of mammalian development. 
For instance, in the developing nervous system neurons are 
generated in excess, compete for limited supplies of survival 
factors and up to 50% of immature neurons are eliminated by 
apoptosis [3,4]. Moreover, it is now recognised that defects in 
apoptosis are associated with a number of neurodegenarative 
diseases [5]. 
Ceramide, the second messenger of the sphingomyelin path-
way, has emerged as a pleotropic mediator that regulates cell 
cycle arrest, differentiation and apoptosis [6,7]. The generation 
of endogenous ceramide is regulated by such agonists as tu-
mour necrosis factor-oc, Fas ligand, interleukin-1, ionising ra-
diation and chemotherapeutic drugs, but the exact mecha-
nisms involved remain to be determined. There is an increas-
ing amount of evidence implicating ceramide as an important 
second messenger in neuronal signalling pathways. Nerve 
growth factor activates the sphingomyelin cycle through the 
p75 neurotrophin receptor, a member of the tumour necrosis 
factor receptor family, resulting in differentiation in T9 glioma 
cells [8]. Likewise, ceramide is involved in the differentiation 
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of neuroblastoma Neuro2a cells [9]. Contrary evidence sug-
gests a role for p75 in the promotion of apoptosis [10-12]. 
Furthermore, it has recently been demonstrated that ceramide 
can induce apoptosis in primary cultures of rat mesencephalic 
neurons [13] and embryonic chick neurons [14]. 
The rat pheochromocytoma PC 12 cell line has been exten-
sively utilised as a model to study the mechanisms regulating 
neuronal survival and apoptotic death [15-17]. Previous re-
ports have indicated that treatment of PC 12 cells with either 
exogenous ceramide [18] or bacterial SMase [19] inhibits nerve 
growth factor-induced differentiation. To our knowledge, cer-
amide effects on apoptosis in these cells have not been re-
ported. 
In the present study we determined the effect of ceramide, 
added exogenously in the form of short-chain ceramide ana-
logs and natural ceramide, on apoptosis in PC12 cells. Our 
results demonstrate that ceramide specifically induces apopto-
sis in PC 12 cells and that the apoptotic response depends 
critically on cell plating density. Furthermore, the peptide in-
hibitor of ICE-like proteases, Z-VAD.FMK, completely pre-
vented the nuclear changes induced by ceramide, implicating 
the involvement of this family of proteases in the terminal 
stages of apoptosis. 
2. Materials and methods 
2.1. Materials 
JV-acetylsphingosine (C2-ceramide), iV-acetylsphinganine (C2-dihy-
droceramide), JV-hexanoylsphingosine (C6-ceramide) and 1,2-diocta-
noyl-sn-glycerol (DAG) were all obtained from Biomol. Natural cer-
amide (type III) and sphingomyelinase (SMase) from S. aureus were 
purchased from Sigma. Arachidonic acid (AA) was from Cayman 
Chemical. Hoechst 33258 was from Calbiochem. Benzyloxycarbo-
nyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) was ob-
tained from Enzyme Systems Products. Stock solutions of lipids were 
prepared in DMSO or ethanol, except natural ceramide (Cer) which 
was prepared in ethanol/dodecane (98:2, v/v), as described by Ji et al. 
[20]. 
2.2. Cell culture 
The rat pheochromocytoma cell line, PC12, was provided by Dr. R. 
Rush (Flinders Medical Centre, Adelaide, SA). Stock cultures were 
maintained in DMEM (high glucose) supplemented with 10% horse 
serum, 5% fetal calf serum (FCS), 100 U/ml penicillin and 100 μg/ml 
streptomycin. For all experiments, PC12 cells were detached by tri-
turation, resuspended in complete DMEM and plated on to poly-L-
ornithine-coated plastic culture dishes for 18-24 h prior to further 
treatments. 
2.3. Determination of apoptosis by fluorescence microscopy 
Morphological determination of levels of apoptosis was performed 
by labelling the cells with the nuclear stain Hoechst 33258 and visual-
isation by fluorescence microscopy. Briefly, PC12 cells, pre-plated in 
6-well plastic culture dishes (4X 104 cells/well), were washed in serum-
free DMEM and resuspended in DMEM (2% FCS) in the presence of 
short-chain ceramide analogs, natural Cer, DAG, AA, or SMase. 
Final concentrations of DMSO or ethanol did not exceed 0.2% and 
in the case of ethanol/dodecane did not exceed 0.198%/0.002%. Treat-
ments were continued for the indicated times and cells were stained 
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with Hoechst 33258 (5 μg/ml). Nuclei (blue) that were condensed or 
fragmented were scored as apoptotic. In all cases solvent alone had no 
effect on the morphological appearance or viability of PC 12 cells. 
2.4. Quantitative cell death ELISA 
PC12 cells (1.2xl05/60 mm dish) were treated for 18 h, removed 
from the dish, centifuged (2000 rpm, 10 min) and washed once. Cy-
toplasmic fractions were prepared from lysates by centrifugation at 
20000Xg for 10 min. The cell death detection ELISA (Boehringer 
Mannheim), which quantitatively determines levels of cytoplasmic 
histone-associated DNA fragments, was performed according to man-
ufacturer's instructions and absorbances were measured at 405 nm. 
2.5. Photomicrography 
Cells were treated for 18 h, washed gently in Krebs-Ringer-Hepes 
buffer, and fixed in paraformaldehyde (4%). After fixation, nuclei were 
stained with Hoechst 33258 (5 μg/ml) and photomicrographs (X400 
magnification) were taken using a Leica Dialux 20 EB microscope. 
2.6. Analysis of internucleosomal DNA fragmentation 
Internucleosomal DNA fragmentation was analysed by agarose gel 
electrophoresis according to the method of Gong et al. [21]. Briefly, 
PC12 cells (5X106) were removed from plates, collected by centrifu-
gation and fixed in 70% ethanol. DNA was extracted with 0.2 M 
phosphate-citrate buffer (pH 7.8), incubated with 0.25% NP-40 and 
RNase A (1 mg/ml) at 37°C for 30 min and treated with proteinase K 
(1 mg/ml) at 37°C for a further 30 min. Samples were loaded on to a 
2% agarose gel and electrophoresis was performed at 5 V/cm for 4 h. 
DNA in gels was visualised under UV light after staining with ethi-
dium bromide (0.5 μg/ml). 
3. Results and discussion 
PC 12 cells were plated at low density and subsequent treat-
ments were in low serum-containing media (2% FCS), since it 
is well recognised that biologically active lipids, such as cer-
amide, can be sequestered by lipid-binding serum proteins 
[22]. In this defined system control PC 12 cells remained at-
tached to the culture substratum and viability was greater 
than 95% for at least 24 h. Addition of exogenous ceramide, 
in the form of the short-chain cell-permeable analog C2-cer-
amide, to PC 12 cells resulted in a number of morphological 
changes that are characteristic of apoptosis. These included 
cell shrinkage, detachment from the substratum, blebbing of 
the cell membrane and, ultimately, an increase in cell death. 
To examine whether these changes induced by exogenous cer-
amide were indeed apoptosis, cells were stained with Hoechst 
33258. The nuclei of control PC12 cells stained uniformly with 
this dye, indicating that the nuclei were intact and the cells 
were viable (Fig. 1A). Conversely, treatment of cells with C2-
ceramide (20 μΜ) caused nuclear fragmentation and conden-
sation (Fig. IB) and increased the levels of apoptosis as de-
termined quantitatively by nuclei staining with Hoechst 33258 
(Fig. 2A) or by a DNA fragmentation ELISA (Fig. 2B). C6-
ceramide, a ceramide analog with a longer 6-carbon fatty acid 
chain, similarly induced apoptosis (Fig. 2A,B). However, this 
analog was maximally effective at a lower concentration (10 
μΜ) and displayed greater cytotoxicity at higher concentra-
tions. Recent observations have demonstrated that natural 
Cer can be delivered to cells using a solvent mixture of etha-
nol and dodecane [20]. Treatment of PC12 cells with natural 
Cer resulted in apoptosis (Fig. 2A,B). Indeed, the effect of 
natural Cer was extremely sensitive in this system, in that 
low concentrations of natural Cer (50 ng/ml) induced high 
levels of apoptosis within 8 h. The specificity of ceramide-
Fig. 1. Morphological appearance of PC12 cells treated with either vehicle alone (A) or 20 μΜ C2-ceramide (B) for 20 h. Nuclei were stained 
with Hoechst 33258 and fluorescence photomicrographs (X400 magnification) were taken. In (C), internucleosomal DNA fragmentation was 
detected by agarose gel electrophoresis of DNA from cells treated with vehicle alone (Control), 20 μΜ C2-dihydroceramide (DHC2-Cer), 20 
μΜ C2-ceramide (C2-Cer), or in the absence of serum (Serum free) for 24 h. The marker is ffindlll digest of λ DNA. 
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Fig. 2. Quantitative determination of apoptosis in PC12 cells. Levels 
of apoptosis were determined by (A) nuclei staining with Hoechst 
33258 and (B) the cell death detection ELISA in PC 12 cells treated 
in the absence (Control) or the presence of 20 μΜ C2-ceramide (C2-
Cer), 10 μΜ C6-ceramide (C6-Cer), 20 μΜ C2-dihydroceramide 
(DHC2-Cer), 20 μΜ ΑΑ, 20 μΜ DAG, or 200 mU/ml SMase for 
20 h, or 50 ng/ml natural ceramide (Cer) for 8 h. In each case the 
data represent means ± S.D. from at least four separate experiments. 
induced apoptosis was investigated by determining the effects 
of structural analogs of ceramide and other related lipids. The 
ceramide analog C2-dihydroceramide, which lacks the C4-5 
trans double bond in the sphingolipid backbone that is neces-
sary for the biological effects of ceramide [23], failed to induce 
a quantitative increase in the levels of apoptosis (Fig. 2A,B). 
In addition, equimolar concentrations (20 μΜ) of DAG and 
AA, structurally related lipid second messengers, failed to in-
itiate apoptosis in PC12 cells (Fig. 2A,B). Further confirma-
tion that ceramide induces apoptosis was evidenced by the 
characteristic pattern of internucleosomal DNA fragmenta-
tion detected by agarose gel electrophoresis of soluble cyto-
plasmic DNA (Fig. 1C). Indeed, treatment with C2-ceramide 
produced a pattern of DNA cleavage similar to that obtained 
from PC 12 cells subjected to serum starvation, a well-defined 
apoptotic trigger [15,16]. No DNA fragmentation was ob-
served in either control cells or cells treated with C2-dihydro-
ceramide for 24 h. 
Recent studies on the membrane localisation of sphingo-
myelin have identified two distinct pools that are defined by 
their sensitivity to hydrolysis by bacterial SMase [24]. The first 
pool is bacterial SMase-sensitive and is located in the outer 
leaflet of the plasma membrane, whereas the second pool is 
internal and resistant to bacterial SMase hydrolysis. In HL-60 
cells, the signalling pool of sphingomyelin is bacterial SMase-
insensitive [24]. Evidence also suggests that neurotrophins mo-
bilise the same bacterial SMase-insensitive pool of sphingo-
myelin [18]. Treatment of PC12 cells with exogenous bacterial 
SMase failed to induce apoptosis (Fig. 2A,B), suggesting that 
in these cells the signalling pool of sphingomyelin does not 
reside in the outer leaflet of the plasma membrane. However, 
in the absence of a distinct agonist that stimulates the hydro-
lysis of sphingomyelin in PC 12 cells it will be difficult to 
accurately determine the location of a putative signalling 
pool pertinent to apoptosis. Although sphingomyelin hydro-
lysis appears to account for the major source of ceramide, 
additional metabolic pathways may be important. Indeed, it 
has been suggested that drug-induced apoptosis involves the 
activation of ceramide synthase resulting in the de novo 
synthesis of ceramide [25]. 
The kinetics of ceramide-induced apoptosis were deter-
mined next. Exogenous C2-ceramide (5-25 μΜ) was added 
to PC 12 cells and levels of apoptosis were assessed after 4 h, 
8 h, 16 h and 24 h (Fig. 3). Basal levels of apoptosis remained 
low ( > 5%) in untreated cells. Little evidence of increased 
apoptosis could be detected with either 5 μΜ or 10 μΜ 
C2-ceramide over 24 h. However, with 15 μΜ and 20 μΜ 
C2-ceramide, apoptosis was markedly increased by 8 h 
(Fig. 3) and by 16 h, 23.2% and 28.1% of cells displayed 
apoptotic morphologies with 15 μΜ and 20 μΜ C2-ceramide, 
respectively. Maximal levels of apoptosis were 27.6% and 
28.6% with 15 μΜ and 20 μΜ C2-ceramide, respectively, at 
24 h. At higher concentrations (^25 μΜ C2-ceramide) the 
apoptotic effect of ceramide declined, but levels of cell death 
were elevated and displayed morphological characteristics of 
necrosis. Together, these data indicate that in PC12 cells cer-
amide induces a time and concentration dependent increase in 
apoptosis. 
Previous work has established that the biological effects of 
exogenously added ceramide in cellular systems are subject to 
surface dilution kinetics [22]. Since PC 12 cells were seeded at 
low cell density in our experiments, it was determined whether 
cell plating density influenced the apoptotic response induced 
Time (h) 
Fig. 3. Kinetics of C2-ceramide-induced apoptosis in PC12 cells. 
PC 12 cells were treated in the absence (·) or the presence of 5 μΜ 
(O), 10 μΜ (Τ), 15 μΜ (v), 20 μΜ (■) and 25 μΜ (Π) C2-cer-
amide for the indicated times. Levels of apoptosis were quantita-
tively determined by Hoechst 33258 staining. Results shown are 
mean data from at least four separate experiments. 
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by C2-ceramide. Experiments were conducted in 35 mm 
dishes; at the standard seeding density (4X 104 cells/well) cer-
amide treatment increased the levels of apoptosis 8-fold (Fig. 
4). As the cell plating density increased, the ability of C2-
ceramide (20 μΜ) to induce apoptosis decreased. Indeed, 
when cells were seeded at a density of 2 x l 0 5 cells/well the 
apoptotic effect of exogenous C2-ceramide disappeared (Fig. 
4). These results demonstrate that in PC12 cells apoptosis 
induced by exogenous ceramide critically depends on cell plat-
ing density. 
It is becoming increasingly apparent that proteases play an 
important role during apoptosis. Recent attention has primar-
ily focused on a family of novel cysteine proteases, termed 
ICE (interleukin-lß converting enzyme)-like proteases, in 
mediating apoptosis [for reviews see [26,27]]. To determine 
whether ceramide-induced apoptosis requires ICE-like pro-
teases, we used the irreversible tripeptide inhibitor Z-
VAD.FMK. This cell permeable inhibitor blocks apoptosis 
induced by diverse stimuli in THP.l cells [28], rat hepatocytes 
[29] and Jurkat T-cells [30]. Evidence indicates that Z-
VAD.FMK inhibits apoptosis by blocking the cleavage of 
CPP32 [31,32]. Our data demonstrate that Z-VAD.FMK in-
hibits C2-ceramide-induced apoptosis, assessed by nuclei 
staining with Hoechst 33258, in PC12 cells (Table 1); Z-
VAD.FMK (50 μΜ) inhibited ceramide-induced apoptosis 
by 51%, whereas Z-VAD.FMK (100 μΜ) completely blocked 
ceramide-induced nuclear changes. Although Z-VAD.FMK 
prevented changes in the nuclear morphology, it failed to 
prevent the cell shrinkage, detachment from the substratum 
and blebbing of the cell membrane observed in apoptosis. 
These data establish a role for ICE-like proteases, in particu-
lar CPP32, in ceramide-induced apoptosis in PC12 cells and 
supports recent evidence demonstrating the activation of 
CPP32 in ceramide-induced apoptosis [33]. 
In summary, our findings show that exogenous ceramide 
can specifically induce apoptosis in PC12 cells. The effect of 
ceramide is time and concentration dependent. Moreover, cer-
amide-induced apoptosis depends critically on cell plating 
density, indicating that apoptosis initiated by exogenously 
added ceramide in PC 12 cells is subject to surface dilution 
kinetics. The failure of bacterial SMase to induce apoptosis 
suggests that if the generation of endogenous ceramide is im-
portant to apoptosis in PC 12 cells, the signalling pool of 
sphingomyelin does not reside in the outer leaflet of the plas-
ma membrane. Finally, our findings establish a role for ICE-
like protease activation in ceramide-induced apoptosis in 
PC12 cells. 
Table 1 
Z-VAD.FMK prevents C2-ceramide-induced apoptosis in PC 12 cells 
Z-VAD.FMK (μΜ) 
50 
Control 3.6 ±0.7 4.2 ±0.6 




PC12 cells were incubated in either the absence or the presence of Z-
VAD.FMK (50 μΜ and 100 μΜ) for 1 h, then further incubated for 
20 h in the absence or the presence of C2-ceramide (20 μΜ). Ζ-
VAD.FMK was present throughout the experiment. The percentage 
of apoptotic cells was determined by nuclei staining with Hoechst 
33258. Results are expressed as means ± S.D. from four separate ex-
periments. 
Cell density (cells x 10 /well) 
Fig. 4. Ceramide-induced apoptosis depends on cell plating density. 
PC 12 cells were treated in either the absence (n) or the presence of 
20 μΜ C2-ceramide (·) for 20 h. Levels of apoptosis were deter-
mined by Hoechst staining. Results shown are means ± S.D. from 
four separate experiments. 
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